Delivery Order SPE2DB22D1106-SPE2DB25FERC9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,295.99 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 12, 2025, with a completion date of August 13, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 sensors are continuous glucose monitoring devices used for diabetes management, supporting the...
- The Defense Logistics Agency awarded a $14,958.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 21, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management within military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,610.79 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 15, 2025, with completion targeted for September 16, 2025. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The Dexcom G7 is a continuous glucose monitoring system used for...
- The Defense Logistics Agency awarded a delivery order valued at $1,846.70 to AmerisourceBergen Drug Corp for Dexcom G7 Sensors on August 20, 2025. This non-competitive, firm fixed-price delivery order is set to be completed by August 21, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 is a continuous glucose monitoring system used for diabetes management, reflecting the federal government's procurement needs for advanced medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.76 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,237.44 to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed-price contract, with an ultimate completion date of September 15, 2025. This is a non-set-aside award issued competitively on September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this order. The Dexcom G7 is a continuous...
- The Defense Logistics Agency awarded a delivery order valued at $1,948.60 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 15, 2025, with an ultimate completion date of July 16, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Dexcom G7 sensors are continuous glucose monitoring devices used for diabetes management and are critical medical supplies...
- The Defense Logistics Agency awarded a delivery order valued at $4,124.80 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management, aligning with the Defense...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $26,818.58 for Dexcom G7 sensors on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 sensors are continuous glucose monitoring devices used in diabetes management across federal...
- The Defense Logistics Agency awarded a $1,525.72 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion through December 2026. The work will be performed at the contractor's corporate office location in...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FERC9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,001.86 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion date of June 3, 2025. This non-set-aside, firm fixed price contract was awarded on June 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management and represents a critical medical supply component for federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a prime vendor for military and veteran healthcare systems, supplying an extensive portfolio of pharmaceutical products and medical devices across multiple therapeutic domains. The company's substantial IDC vehicle enables flexible fulfillment of federal medical supply requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 6/2/25 |